- Highly efficient cash conversion (100% FCF/OCF ratio)
- Established player in the Healthcare sector
Big movements in Jasper Therapeutics, Inc. stock price on Monday moving 17.24% between high and low
(Updated on Jul 13, 2026)
The Jasper Therapeutics, Inc. stock price gained 4.90% on the last trading day (Monday, 13th Jul 2026), rising from $0.580 to $0.608. During the last trading day the stock fluctuated 17.24% from a day low at $0.580 to a day high of $0.680. The price has risen in 8 of the last 10 days and is up by 78.27% over the past 2 weeks. Volume fell on the last day by -105 thousand shares and in total, 1 million shares were bought and sold for approximately $816.62 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Given the current short-term trend, the stock is expected to fall -52.83% during the next 3 months and, with a 90% probability hold a price between $0.108 and $0.287 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
JSPR Signals & Forecast
The Jasper Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.523 and $0.551. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 26, 2026, and so far it has risen 78.27%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Jasper Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.551 and $0.534. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Jasper Therapeutics, Inc. finds support just below today's level at $0.551. If this is broken, then the next support from accumulated volume will be at $0.534 and $0.502.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.100 between high and low, or 17.24%. For the last week the stock has had daily average volatility of 20.23%.
Our recommended stop-loss: $0.588 (-3.28%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 10 days ago.)
Trading Expectations (JSPR) For The Upcoming Trading Day Of Tuesday 14th
For the upcoming trading day on Tuesday, 14th we expect Jasper Therapeutics, Inc. to open at $0.623, and during the day (based on 14 day Average True Range), to move between $0.566 and $0.650, which gives a possible trading interval of +/-$0.0838 (+/-14.81%) up or down from last closing price. If Jasper Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 14.81% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $0.551, some $0.0566 (9.31%) from the current price of $0.608, our system finds the risk reward attractive.
Is Jasper Therapeutics, Inc. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score:
2.858
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 14, 2026 - $0.623 ( 2.42%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
JSPR Performance
Trading levels for JSPR
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.723 | 18.87% |
| R2 | 0.684 | 12.59% |
| R1 | 0.661 | 8.71% |
| Price | 0.608 | |
| S1 | 0.584 | -3.86% |
| S2 | 0.561 | -7.74% |
| S3 | 0.523 | -14.03% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 0.608 | |
| S1 | 0.551 | -9.31% |
| S2 | 0.534 | -12.12% |
| S3 | 0.502 | -17.50% |
FAQ
Click here for our free guide on how to buy Jasper Therapeutics, Inc. Stock.
Buy JSPR